Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study

Division of Cardiology, University Hospital, Zurich, Switzerland.

In a retrospective analysis 139 patients with hypertrophic cardiomyopathy were followed up for 8.9 years (range 1 to 28 years). Patients were divided into two groups: Group 1 consisted of 60 patients with medical therapy and Group 2 of 79 patients with surgical therapy (septal myectomy). Groups 1 and 2 were subdivided according to the medical treatment. Group 1a received propranolol, 160 mg/day (n = 20); Group 1b verapamil, 360 mg/day (n = 18); and Group 1c, no therapy (n = 22). Group 2a received verapamil, 120 to 360 mg/day, after septal myectomy (n = 17) and Group 2b had no medical therapy after surgery (n = 62). In Group 1, 19 patients died (annual mortality rate 3.6%) and in Group 2, 17 patients died (mortality rate 2.4%, p = NS). Of the patients who died, approximately one half to two thirds in both Groups 1 and 2 died suddenly and the other one half to one third died because of congestive heart failure. The 10 year cumulative survival rate was 67% in Group 1, significantly smaller than that in Group 2 (84%, p less than 0.05). In the subgroups, the 10 year survival rate was 67% in Group 1a, 80% in 1b (p less than 0.05 versus 1a) and 65% in 1c (p less than 0.05 versus 1b). The 10 year survival rate was 100% in Group 2a (p less than 0.05 versus 1a, 1b, 1c) and 78% in Group 2b (p less than 0.05 versus 2a). It is concluded that cumulative survival rate is significantly better in surgically than in medically treated patients.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]

				C. J. McLeod, S. R. Ommen, M. J. Ackerman, P. L. Weivoda, W. K. Shen, J. A. Dearani, H. V. Schaff, A. J. Tajik, and B. J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur. Heart J., November 1, 2007; 28(21): 2583 - 2588. [Abstract] [Full Text] [PDF]

				B. J. Maron Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy Circulation, July 10, 2007; 116(2): 196 - 206. [Full Text] [PDF]

				A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy Circulation, April 26, 2005; 111(16): 2033 - 2041. [Abstract] [Full Text] [PDF]

				B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053. [Abstract] [Full Text] [PDF]

				O. M. Hess and U. Sigwart New treatment strategies for hypertrophic obstructive cardiomyopathy: Alcohol ablation of the septum: the new gold standard? J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2054 - 2055. [Abstract] [Full Text] [PDF]

				M. Jorg-Ciopor, M. Namdar, J. Turina, R. Jenni, J. Schwitter, M. Turina, O. M. Hess, and P. A. Kaufmann Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 163 - 169. [Abstract] [Full Text] [PDF]

				M. J. M. Kofflard, F. J. Ten Cate, C. van der Lee, and R. T. van Domburg Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration J. Am. Coll. Cardiol., March 19, 2003; 41(6): 987 - 993. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, S. R. Ommen, N. M. Lakkis, D. Killip, W. A. Zoghbi, H. V. Schaff, G. K. Danielson, M. A. Quinones, A. J. Tajik, and W. H. Spencer III Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1701 - 1706. [Abstract] [Full Text] [PDF]

				L. Ryden and F. Gadler Pharmacological therapy for hypertrophic cardiomyopathy: what is the evidence for success? Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L21 - L25. [Abstract] [PDF]

				F.A. Schoendube Surgical treatment of hypertrophic obstructive cardiomyopathy Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L26 - L31. [Abstract] [PDF]

				R. Flores-Ramirez, N. M. Lakkis, K. J. Middleton, D. Killip, W. H. Spencer III, and S. F. Nagueh Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., January 1, 2001; 37(1): 208 - 214. [Abstract] [Full Text] [PDF]

				I. Ostman-Smith, G.o. Wettrell, and T. Riesenfeld A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1813 - 1822. [Abstract] [Full Text] [PDF]

				S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196. [Abstract] [Full Text] [PDF]

				L.J. Kappenberger, C. Linde, X. Jeanrenaud, C. Daubert, W. McKenna, E. Meisel, N. Sadoul, L. Chojnowska, L. Guize, D. Gras, et al. Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy Europace, January 1, 1999; 1(2): 77 - 84. [Abstract] [PDF]

				M. H. Schonbeck, H. P. Brunner-La Rocca, P. R. Vogt, M. L. Lachat, R. Jenni, O. M. Hess, and M. I. Turina Long-Term Follow-up in Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy Ann. Thorac. Surg., May 1, 1998; 65(5): 1207 - 1214. [Abstract] [Full Text] [PDF]

				M. K. Gol, M. Emir, T. Keles, S. A. Kucuker, C. L. Birincioglu, Y. H. Karagoz, T. Kural, O. Tasdemir, S. Goksel, and K. Bayazit Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy: Late Results With Stress Echocardiography Ann. Thorac. Surg., September 1, 1997; 64(3): 739 - 745. [Abstract] [Full Text]

				C. Knight, A. S. Kurbaan, H. Seggewiss, M. Henein, M. Gunning, D. Harrington, D. Fassbender, U. Gleichmann, and U. Sigwart Nonsurgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy : Outcome in the First Series of Patients Circulation, April 15, 1997; 95(8): 2075 - 2081. [Abstract] [Full Text]

				A. Hartmann, J. Schnell, R. Hopf, and G. Kneissl Persisting Effect of Ca2+-Channel Blockers on Left Ventricular Function in Hypertrophic Cardiomyopathy After 14 Years' Treatment Angiology, August 1, 1996; 47(8): 765 - 773. [Abstract] [PDF]

				R. B. McCully, R. A. Nishimura, A. J. Tajik, H. V. Schaff, and G. K. Danielson Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy Circulation, August 1, 1996; 94(3): 467 - 471. [Abstract] [Full Text]

				R. C. Robbins and E. B. Stinson LONG-TERM RESULTS OF LEFT VENTRICULAR MYOTOMY AND MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 586 - 594. [Abstract] [Full Text]

				J. A. Quinones, S. Y. DeLeon, D. A. Vitullo, J. Hofstra, D. J. Cziperle, K. P. Shenoy, T. J. Bell, and E. A. Fisher Regression of Hypertrophic Cardiomyopathy After Modified Konno Procedure Ann. Thorac. Surg., November 1, 1995; 60(5): 1250 - 1254. [Abstract] [Full Text]

				F. A. Schoendube, H. G. Klues, S. Reith, F. A. Flachskampf, P. Hanrath, and B. J. Messmer Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus Circulation, November 1, 1995; 92(9): 122 - 127. [Abstract] [Full Text]

				B. Heric, B. W. Lytle, D. P. Miller, E. R. Rosenkranz, H. M. Lever, and D. M. Cosgrove Surgical management of hypertrophic obstructive cardiomyopathy:Early and late results J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 195 - 208. [Abstract] [Full Text]

				J. Schwartz, C. Rafael, V. Rozenfeld, Z. Abu-Much, and H. Schoham Change of the Degree of Septal Hypertrophy in Hypertrophic Obstructive Cardiomyopathy Under Procainamide Treatment: A Case Report Angiology, January 1, 1995; 46(1): 83 - 85. [Abstract] [PDF]